BACKGROUND: Ultrathin unsedated transnasal gastroscopy (UTEG) has a number of advantages applicable to eosinophilic esophagitis (EoE) and has not been evaluated for this condition. AIM: The aim of the study is to determine the feasibility of UTEG in patients with EoE and the acceptability of histological specimens obtained at biopsy. METHOD: All patients with a diagnosis of EoE presenting to the outpatients department of two hospitals (Box Hill Hospital and The Alfred Hospital, Melbourne Australia) were asked to participate in the study. UTEG was performed on consenting individuals. Feasibility was determined by the success of nasal intubaton, patient perception according to post procedural survey, and adequacy of esophageal biopsies was assessed. RESULTS: Ninety-six consecutive patients with EoE were offered UTEG, and 24 agreed to participate in the study. Seventy-four UTEGs were performed over a period of 26 months (September 2012 to December 2014). Nineteen patients had repeat procedures. Successful nasal intubation occurred in 97% (72 of 74 procedures), and 21 of 24 (86%) described high satisfaction with the procedure and minimal discomfort, and would choose UTEG for future procedures. Mean duration was 5 min. Adverse events of epistaxis (three cases) and vomiting of liquid contents during the procedure (two cases) were recorded, cardiorespiratory parameters remaining normal in all patients. All completed procedures produced adequate histological samples. CONCLUSION: In those who decide to undergo UTEG, it is a safe and well-tolerated procedure.
BACKGROUND: Ultrathin unsedated transnasal gastroscopy (UTEG) has a number of advantages applicable to eosinophilic esophagitis (EoE) and has not been evaluated for this condition. AIM: The aim of the study is to determine the feasibility of UTEG in patients with EoE and the acceptability of histological specimens obtained at biopsy. METHOD: All patients with a diagnosis of EoE presenting to the outpatients department of two hospitals (Box Hill Hospital and The Alfred Hospital, Melbourne Australia) were asked to participate in the study. UTEG was performed on consenting individuals. Feasibility was determined by the success of nasal intubaton, patient perception according to post procedural survey, and adequacy of esophageal biopsies was assessed. RESULTS: Ninety-six consecutive patients with EoE were offered UTEG, and 24 agreed to participate in the study. Seventy-four UTEGs were performed over a period of 26 months (September 2012 to December 2014). Nineteen patients had repeat procedures. Successful nasal intubation occurred in 97% (72 of 74 procedures), and 21 of 24 (86%) described high satisfaction with the procedure and minimal discomfort, and would choose UTEG for future procedures. Mean duration was 5 min. Adverse events of epistaxis (three cases) and vomiting of liquid contents during the procedure (two cases) were recorded, cardiorespiratory parameters remaining normal in all patients. All completed procedures produced adequate histological samples. CONCLUSION: In those who decide to undergo UTEG, it is a safe and well-tolerated procedure.
Authors: Caroline H T Hall; Nathalie Nguyen; Glenn T Furuta; Jeremy Prager; Emily Deboer; Robin Deterding; Calies Menard-Katcher; Kelley E Capocelli; Robert E Kramer; Joel A Friedlander Journal: J Pediatr Gastroenterol Nutr Date: 2018-01 Impact factor: 2.839
Authors: Ian F Slack; Justin T Schwartz; Vincent A Mukkada; Shawna Hottinger; J Pablo Abonia Journal: Curr Allergy Asthma Rep Date: 2020-06-06 Impact factor: 4.806
Authors: Nathalie Nguyen; William J Lavery; Kelley E Capocelli; Clinton Smith; Emily M DeBoer; Robin Deterding; Jeremy D Prager; Kristina Leinwand; Greg E Kobak; Robert E Kramer; Calies Menard-Katcher; Glenn T Furuta; Dan Atkins; David Fleischer; Matthew Greenhawt; Joel A Friedlander Journal: Clin Gastroenterol Hepatol Date: 2019-01-29 Impact factor: 11.382
Authors: Joel A Friedlander; David M Fleischer; Jennifer O Black; Meredith Levy; Marc E Rothenberg; Clinton Smith; Nathalie Nguyen; Zhaoxing Pan; Glenn T Furuta Journal: J Allergy Clin Immunol Pract Date: 2021-07-02